Compare drug alternatives
Emgality® Alternatives
Emgality®
(Galcanezumab)
Emgality
-
Migraine
- Aimovig®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Emgality is a medication that can be self-administered once a month by injecting it subcutaneously under the skin. It is used for migraine prevention in adults and can also be used to treat cluster headaches during a cluster headache period. The most frequently reported side effect is injection site reactions. Additionally, there are no known drug interactions with Emgality.
Emgality is FDA approved for the following indications: Migraine and Cluster Headaches.
Vyepti®
(eptinezumab-jjmr)
Vyepti
-
Migraine
- Aimovig®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Vypeti is a prescription medication used for migraine prevention. It is administered as an intravenous infusion four times a year. The most common reported side effects were stuffy nose and scratchy throat.
Vyepti is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Subcutaneous
Intravenous infusion (must be diluted)
Dosing
Migraine: 240 mg loading dose (120 mg x 2) followed by 120 mg monthly.
100 mg every 3 months or 300 mg (for some patients)
Latin Shorthand
240 mg LD (120 mg x 2) then 120 mg/mo.
100 mg q3mo
Financial Assistance
Copay
$0
$0
Annual Cap
$4,900
$200 per infusion for administration costs
Assistance Expiration
12 months
Calendar year
Generics
No lower-cost generic available
No lower-cost generic available